CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer (CY503C2)

This study has been terminated.
(The sponsor declared the early termination of the study due to poor recruitment of patients.)
ClinAssess GmbH
Medical University Innsbruck
Charite University, Berlin, Germany
Information provided by:
Cytavis Biopharma GmbH Identifier:
First received: June 25, 2009
Last updated: July 9, 2013
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)